national
CVS and Walgreens Fill Over 200,000 Prescriptions Under Medicare Obesity Drug Program
Just the facts
Major pharmacy operators CVS Health and Walgreens Boots Alliance reported processing more than 100,000 prescriptions each under the federal Medicare Bridge program since its implementation on July 1. The initiative allows eligible Medicare beneficiaries to access approved GLP-1 weight-loss medications for a capped co-payment of $50 per month. Federal health authorities established the program to lower out-of-pocket costs and expand access to anti-obesity prescription drugs for older adults. The prescription volume reflects growing demand among Medicare recipients for subsidized weight-management treatments across nationwide pharmacy locations.
Why this is news
Retail pharmacy chains CVS and Walgreens reported filling over 100,000 prescriptions each under Medicare's Bridge program offering $50 monthly obesity medications.
Sources
This summary is compiled strictly from the original reporting below.